Filing Flows

Filing Flows › Companies › Gentex › Cash flow

Gentex cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$64.1M in Q3 2026 · $449M over twelve months

Operating cash flow$84.1M
Capital spending−$20.0M
Free cash flow+$64.1M
Cash / net income0.9×
Cash conversion cycle116 days

Analysis

In Q3 2026, Gentex generated $84.1M of operating cash flow and spent $20.0M on capital projects, leaving free cash flow of $64.1M. That is $47.3M less than in Q3 2025 ($111M).

Over the twelve months to Sep 30, 2026, operating cash flow was $531M; the largest uses were buybacks ($358M), dividends ($103M), capital spending ($81.9M); besides operations, cash came from asset & business sales ($11.2M), shares issued ($6.3M); the cash balance fell by $44.9M.

Operating cash flow was $84.1M against net income of $90.6M — 0.9× profit, roughly in line with earnings. The largest differences: inventory −$31.1M, depreciation & amortization +$25.7M, receivables −$18.2M.

Its cash conversion cycle was 116 days (receivables 56 + inventory 114 − payables 55).

Free cash flow

Gentex: free cash flow by quarterGentex: free cash flow by quarter$113MQ4 2024$112MQ1 2025$135MQ2 2025$111MQ3 2025$99.8MQ4 2025$120MQ1 2026$165MQ2 2026$64.1MQ3 2026
Operating cash flow less capital spending.
Gentex: operating cash flow against capital spendingGentex: operating cash flow against capital spendingOperating cash flowCapital spending$154M$41.7MQ4 2024$149M$36.7MQ1 2025$166M$31.1MQ2 2025$147M$35.6MQ3 2025$125M$25.7MQ4 2025$137M$17.0MQ1 2026$185M$19.2MQ2 2026$84.1M$20.0MQ3 2026
Latest (Q3 2026): Operating cash flow $84.1M, Capital spending $20.0M.

Capital allocation, year by year

Gentex: where the cash came from (up) and went (down), by fiscal yearGentex: where the cash came from (up) and went (down), by fiscal yearOperating cash flowShares issuedAsset salesCapital spendingAcquisitionsBuybacksDividendsFY2021: Operating cash flow $362MFY2021: Shares issued $29.8MFY2021: Asset sales $2.6MFY2021: Capital spending −$68.8MFY2021: Acquisitions −$12.1MFY2021: Buybacks −$325MFY2021: Dividends −$115M$395MFY2021FY2022: Operating cash flow $338MFY2022: Shares issued $16.6MFY2022: Asset sales $314KFY2022: Capital spending −$146MFY2022: Buybacks −$113MFY2022: Dividends −$113M$355MFY2022FY2023: Operating cash flow $537MFY2023: Shares issued $29.4MFY2023: Asset sales $293KFY2023: Capital spending −$184MFY2023: Acquisitions −$18.9MFY2023: Buybacks −$147MFY2023: Dividends −$112M$567MFY2023FY2024: Operating cash flow $498MFY2024: Shares issued $27.3MFY2024: Asset sales $3.3MFY2024: Capital spending −$145MFY2024: Acquisitions −$2.9MFY2024: Buybacks −$206MFY2024: Dividends −$110M$529MFY2024FY2025: Operating cash flow $587MFY2025: Shares issued $14.5MFY2025: Asset sales $8.4MFY2025: Capital spending −$129MFY2025: Acquisitions −$156MFY2025: Buybacks −$315MFY2025: Dividends −$107M$610MFY2025
Over these 5 years operating cash flow totalled $2.3B; the largest uses were buybacks ($1.1B) and capital spending ($673M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$146M
Debtnone
Net cash$146M

Gentex funds itself: free cash flow was $449M over the last twelve months, with $146M of cash and investments and no debt on the balance sheet.

Where the cash came from and went

Gentex: sources (+) and uses (−) of cash, Q3 2026Gentex: sources (+) and uses (−) of cash, Q3 2026Buybacks−$134MCash drawn (+) / kept (−)$97.0MOperating cash flow$84.1MDividends−$25.3MCapital spending−$20.0MOther investing−$4.8MAsset & business sales$2.6MShares issued$1.2MOther financing−$1.2M
Gentex: sources (+) and uses (−) of cash, TTM to Q3 2026Gentex: sources (+) and uses (−) of cash, TTM to Q3 2026Operating cash flow$531MBuybacks−$358MDividends−$103MCapital spending−$81.9MOther investing−$49.7MCash drawn (+) / kept (−)$44.9MAsset & business sales$11.2MShares issued$6.3MOther financing−$1.2MAcquisitions−$331

From profit to cash

Gentex: net income to operating cash flow, Q3 2026Gentex: net income to operating cash flow, Q3 2026Net income$90.6MDepreciation & amortization$25.7MStock-based pay$9.6MDeferred taxes−$5.0MImpairments$3.0MReceivables−$18.2MInventory−$31.1MPayables$14.0MAccrued liabilities−$12.6MPrepaid and other assets−$4.4MOperating cash flow$84.1M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 20265611455116
Q2 20265611658114
Q1 20265210553104
Q4 20255411155110
Q3 20255310449109
Q2 2025499339103
Q1 2025499939109
Q4 20245511244123

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsBuybacksDividendsShares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$84.1M−$20.0M—−$134M−$25.3M$1.2M$97.0M$64.1M
Q2 2026$185M−$19.2M—−$69.2M−$25.6M$1.9M−$68.7M$165M
Q1 2026$137M−$17.0M—−$68.6M−$25.9M$2.1M−$19.1M$120M
Q4 2025$125M−$25.7M−$331−$86.5M−$26.3M$1.1M$35.7M$99.8M
Q3 2025$147M−$35.6M−$13.0M−$30.2M−$26.3M$7.1M−$61.6M$111M
Q2 2025$166M−$31.1M—−$131M−$27.0M$1.4M$167M$135M
Q1 2025$149M−$36.7M—−$67.8M−$27.3M$4.9M−$53.2M$112M
Q4 2024$154M−$41.7M−$2.9M−$21.5M−$27.3M$3.3M−$53.7M$113M

Gentex: income statement and cash flow

Gentex, Q3 2026: revenue $648M (-1% year over year), operating margin 17.8%. The chart follows the revenue to costs, profit and cash.

Gentex: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.